Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Capital Expenditures (2017 - 2025)

TrueBlue (TBI) has disclosed Capital Expenditures for 17 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 9294.12% to $3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.7 million, a 1002.53% increase, with the full-year FY2025 number at $15.7 million, up 1002.53% from a year prior.
  • Capital Expenditures was $3.1 million for Q4 2025 at TrueBlue, down from $3.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $32.6 million in Q4 2021 to a low of -$19.7 million in Q4 2023.
  • A 5-year average of $4.3 million and a median of $3.7 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: plummeted 2649.53% in 2022, then soared 9294.12% in 2025.
  • TrueBlue's Capital Expenditures stood at $32.6 million in 2021, then dropped by 15.69% to $27.5 million in 2022, then plummeted by 171.62% to -$19.7 million in 2023, then surged by 99.83% to -$34000.0 in 2024, then skyrocketed by 9294.12% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for TBI's Capital Expenditures are $3.1 million (Q4 2025), $3.6 million (Q3 2025), and $7.6 million (Q2 2025).